Access cutting-edge bipolar depression treatment through this clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.
Access bipolar depression specialists in Ann Arbor at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bipolar depression treatment provided free
This is a sequential multiple assignment randomized trial for adults (ages \> 18) with a bipolar disorder type 1 diagnosis currently experiencing a depressive episode. It is a randomized pragmatic trial that will compare four commonly prescribed treatments for bipolar depression, which includes three FDA-approved medications (Cariprazine, Quetiapine and Lurasidone) and one antipsychotic/antidepressant combination (Aripiprazole/Escitalopram).
Sponsor: Massachusetts General Hospital
Check if you qualify for this bipolar depression clinical trial in Ann Arbor, MI
If you're searching for bipolar depression treatment options in Ann Arbor, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Ann Arbor research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bipolar depression specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.